Skip to main content
MRNA
NASDAQ Life Sciences

Moderna Posts 38-Cent Q3 EPS, Swinging to Profit

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$237
Mkt Cap
$96.399B
52W Low
$22.28
52W High
$261
52W Position info
964% above low
Off High info
9.2% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MRNA has more than doubled off its 52-week low of $22.28.

Summary

Moderna reported third-quarter earnings per share of 38 cents, a swing to profitability after the company posted a $782 million net loss in the second quarter, on revenue of $1.31 billion. The result lands after a transformative stretch: the intismeran melanoma vaccine data in August sent shares up 177% in a single session, and the company raised $3.0 billion in convertible notes at a 47.5% conversion premium in early September. A profitable quarter supports the case that the cancer vaccine franchise and the newly approved flu and COVID products can carry the P&L while the core COVID business normalizes. Guidance and the margin bridge are not yet in hand.

At the time of this announcement, MRNA was trading at $237.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $96.4B. The 52-week trading range was $22.28 to $261.00. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

MRNA - Latest Insights

MRNA
Nov 12, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $247.31
Real-time Price: $204.88 info
Change: -$42.44 (-17%) info
Market Cap: $82.988B info
MRNA
Nov 07, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $256.92
Real-time Price: $204.88 info
Change: -$52.04 (-20%) info
Market Cap: $82.988B info
MRNA
Nov 06, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $255.50
Real-time Price: $204.88 info
Change: -$50.63 (-20%) info
Market Cap: $82.988B info
MRNA
Nov 06, 2026, 1:11 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $258.37
Real-time Price: $204.88 info
Change: -$53.50 (-21%) info
Market Cap: $82.988B info
MRNA
Nov 06, 2026, 7:07 AM EST
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $265.00
Real-time Price: $204.88 info
Change: -$60.13 (-23%) info
Market Cap: $82.988B info